Understand applying the emerging Semantic Web (SW) technologies to FDA’s regulations. Describe the process for development of linked, searchable and easily accessible regulations Understand the benefits of the Semantic Web (SW) technologies for FDA reviewers and other stakeholders.

Learning Objective: The FDA and pharmaceutical companies rely heavily on 21 CFR for their daily operations, and reference specific 21CFR sections and paragraphs in their work. Currently, FDA reviewers have few capabilities for automated visualization tools for searching key words. An ontology-based knowledge management tools focusing on 21 CFR will eliminate inefficiency in the work of the clinical reviewer.

Authors:

Mitra Rocca, US Food and Drug administration
Md Rashedul Hasan (Presenter)
US Food and Drug administration

Presentation Materials:

• Abstract/Manuscript - 1